DK2401383T3 - Fremgangsmåder til udvælgelse af eukaryote celler, som udtrykker et heterologt protein - Google Patents

Fremgangsmåder til udvælgelse af eukaryote celler, som udtrykker et heterologt protein

Info

Publication number
DK2401383T3
DK2401383T3 DK10709687.7T DK10709687T DK2401383T3 DK 2401383 T3 DK2401383 T3 DK 2401383T3 DK 10709687 T DK10709687 T DK 10709687T DK 2401383 T3 DK2401383 T3 DK 2401383T3
Authority
DK
Denmark
Prior art keywords
methods
cells expressing
eukaryotic cells
heterologous protein
selecting eukaryotic
Prior art date
Application number
DK10709687.7T
Other languages
English (en)
Inventor
Thomas Jostock
Hans-Peter Knopf
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK2401383T3 publication Critical patent/DK2401383T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK10709687.7T 2009-02-27 2010-02-26 Fremgangsmåder til udvælgelse af eukaryote celler, som udtrykker et heterologt protein DK2401383T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09154000 2009-02-27
PCT/EP2010/001223 WO2010097239A1 (en) 2009-02-27 2010-02-26 Methods for selecting eukaryotic cells expressing a heterologous protein

Publications (1)

Publication Number Publication Date
DK2401383T3 true DK2401383T3 (da) 2013-12-16

Family

ID=40451117

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10709687.7T DK2401383T3 (da) 2009-02-27 2010-02-26 Fremgangsmåder til udvælgelse af eukaryote celler, som udtrykker et heterologt protein

Country Status (17)

Country Link
US (2) US8962274B2 (da)
EP (1) EP2401383B1 (da)
JP (2) JP5745431B2 (da)
KR (1) KR101706399B1 (da)
CN (1) CN102333875B (da)
AU (1) AU2010219088B2 (da)
BR (1) BRPI1008762B8 (da)
CA (1) CA2753813C (da)
DK (1) DK2401383T3 (da)
ES (1) ES2440321T3 (da)
IL (1) IL214620A (da)
MX (1) MX2011009023A (da)
PL (1) PL2401383T3 (da)
PT (1) PT2401383E (da)
RU (1) RU2551229C2 (da)
SG (1) SG173457A1 (da)
WO (1) WO2010097239A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011009025A (es) 2009-02-27 2011-09-28 Novartis Ag Sistema de vector de expresion que comprende dos marcadores de seleccion.
EP2401383B1 (en) * 2009-02-27 2013-09-18 Novartis AG Methods for selecting eukaryotic cells expressing a heterologous protein
WO2013041487A1 (en) * 2011-09-21 2013-03-28 F. Hoffmann-La Roche Ag Co2 profile cultivation
DK3412684T3 (da) 2013-07-31 2022-07-04 Novartis Ag Nye selektionsvektorer og fremgangsmåder til selektering af eukaryotiske værtsceller
SG11201706617SA (en) * 2015-04-03 2017-09-28 Selexis Sa Use of vitamins and vitamin metabolic genes and proteins for recombinant protein production in mammalian cells
UY37758A (es) 2017-06-12 2019-01-31 Novartis Ag Método de fabricación de anticuerpos biespecíficos, anticuerpos biespecíficos y uso terapéutico de dichos anticuerpos

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2585532B2 (ja) * 1986-05-10 1997-02-26 三井東圧化学株式会社 動物細胞の形質転換体及びそれを得る方法並びにその形質転換体を用いてt−PAを生産する方法
WO1991003554A1 (en) 1989-09-01 1991-03-21 Genentech, Inc. Cells transfected with nucleic acid encoding gtp
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
AR008077A1 (es) 1996-07-26 1999-12-09 Talarico Salinas Laura Beatriz Un polipeptido de fusion o una sal del mismo, su uso, un proceso para prepararlos, una composicion farmaceutica que los comprende, y un vector.
JP4031154B2 (ja) * 1999-07-30 2008-01-09 独立行政法人科学技術振興機構 遺伝子増幅細胞の迅速選択法
EP1349873B1 (en) 2000-09-14 2009-04-01 Beth Israel Deaconess Medical Center, Inc. Modulation of il-2- and il-15-mediated t cell responses
EP1453948A2 (en) 2001-11-28 2004-09-08 Sandoz Gmbh Cell culture process
US7384744B2 (en) * 2002-11-29 2008-06-10 Boehringer Ingelheim Pharma Gmbh & Co., Kg Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products
TW200513351A (en) * 2003-07-17 2005-04-16 Availvs Corp High pressure water jet surface cutting device and cutting method
EP1533617A1 (en) 2003-11-19 2005-05-25 RMF Dictagene S.A. Angiogenesis inhibiting molecules, their selection, production and their use in the treatment and diagnosis of cancer
EP1953222A1 (en) 2007-01-24 2008-08-06 Boehringer Ingelheim Pharma GmbH & Co. KG Improvement of cell growth
SG182953A1 (en) * 2007-03-30 2012-08-30 Abbott Lab Recombinant expression vector elements (reves) for enhancing expression of recombinant proteins in host cells
EP2401383B1 (en) * 2009-02-27 2013-09-18 Novartis AG Methods for selecting eukaryotic cells expressing a heterologous protein

Also Published As

Publication number Publication date
KR20110123783A (ko) 2011-11-15
AU2010219088B2 (en) 2012-11-01
WO2010097239A1 (en) 2010-09-02
US8962274B2 (en) 2015-02-24
CA2753813C (en) 2018-12-11
BRPI1008762B1 (pt) 2020-10-27
PL2401383T3 (pl) 2014-02-28
CN102333875B (zh) 2014-04-16
BRPI1008762A2 (pt) 2015-08-25
US20110306095A1 (en) 2011-12-15
US20140154739A1 (en) 2014-06-05
EP2401383A1 (en) 2012-01-04
RU2551229C2 (ru) 2015-05-20
JP2012518991A (ja) 2012-08-23
AU2010219088A1 (en) 2011-08-18
BRPI1008762B8 (pt) 2021-05-25
IL214620A (en) 2016-02-29
KR101706399B1 (ko) 2017-02-13
MX2011009023A (es) 2011-09-28
SG173457A1 (en) 2011-09-29
CA2753813A1 (en) 2010-09-02
IL214620A0 (en) 2011-09-27
JP2015107120A (ja) 2015-06-11
RU2011139183A (ru) 2013-04-10
EP2401383B1 (en) 2013-09-18
CN102333875A (zh) 2012-01-25
ES2440321T3 (es) 2014-01-28
PT2401383E (pt) 2013-12-16
US9315844B2 (en) 2016-04-19
JP5745431B2 (ja) 2015-07-08

Similar Documents

Publication Publication Date Title
DK3159001T3 (da) Hidtil ukendt fremgangsmåde til fremstilling af differentierede celler
DK3287525T3 (da) RNA-præparater omfattende oprenset modificeret RNA til omprogrammering af celler
EP2378719A4 (en) METHOD FOR IMPLEMENTING RAPID REROUTING
BRPI1009416A2 (pt) célula solar.
DK2569129T3 (da) Fremgangsmåde til styring af en automatiseret arbejdscelle
BR112012000107A2 (pt) receptores de células t.
DK2451643T3 (da) Foliefrit emballagelaminat, fremgansgmåde til fremstilling af emballagelaminat og emballagebeholder deraf
DK1959130T4 (da) Fremgangsmåde til at optimere driften af en vindmølle
BR112012003386A2 (pt) método para comunicação com um nó correspondente, e, nó hospedeiro.
DK2580156T4 (da) Fremgangsmåde til lagring af hydrogen
BRPI1009795A2 (pt) separador centrífugo, e, método em um separador centrífugo.
DK2369432T3 (da) Testsystem til optimering af vindmølledrift
EP2508677A4 (en) UNDERWATER STRUCTURE, CONSTRUCTION METHOD THEREFOR, METHOD FOR DESIGNING A UNDERWATER STRUCTURE AND CONVERSION METHOD THEREFOR
DK2348215T3 (da) Fremgangsmåde til planering af ujævnheder af havbunden
DK2569130T3 (da) Fremgangsmåde til styring af en automatiseret arbejdscelle
DK2432975T3 (da) Fremgangsmåde til at generere elektrisk energi, og anvendelse af et arbejdsmedium
BRPI0924664A2 (pt) eletrodo ,e ,método para construir um eletrodo.
DK2401383T3 (da) Fremgangsmåder til udvælgelse af eukaryote celler, som udtrykker et heterologt protein
BRPI1007317A2 (pt) corrente para gerador eólico troposférico.
DK2472055T3 (da) Værktøj til tilvejebringelse af kunstigt løft
DK2417152T3 (da) Fremgangsmåde til isolering af linaclotid
DK2385248T3 (da) Leje, især til en vindturbine
DK2469081T3 (da) Kontrolsystem, vindmøllepark og metoder til optimering af driften af en vindmølle
BRPI1013889A2 (pt) Célula de levedura, e, método para gerar uma célula de levedura.
DK2302202T3 (da) Hydraulisk fremdrivning til forøgelse af hydroelektrisk kraftværkskapacitet